Literature DB >> 27776221

Establishment of reference intervals for procalcitonin in healthy pregnant women of Chinese population.

Yun Hu1, Mengyuan Yang1, Yang Zhou1, Yiling Ding2, Zhongyuan Xiang3, Ling Yu1.   

Abstract

OBJECTIVE: To establish reference intervals (RIs) for procalcitonin (PCT) in healthy pregnant women of Chinese population.
METHODS: Serum PCT levels were measured by electrochemiluminescence immunoassay (ECLIA) in 1246 healthy Chinese women, including 124 cases in the first trimester, 128 cases in the second trimester, 125 cases in the third trimester, 125 cases of vaginal delivery, 124 cases at the 3rd day after vaginal delivery, 122 cases at the 10th day after vaginal delivery, 126 cases with Cesarean delivery, 126 cases at the 3rd day after Cesarean delivery, 124 cases at the 10th day after Cesarean delivery, and 122 cases involving non-pregnant women. All cases were independent. The RIs for PCT were defined using nonparametric 95% intervals.
RESULTS: The RIs for PCT were 0.018-0.051μg/L for the first and second trimester; 0.020-0.152μg/L for the third trimester; 0.022-0.195μg/L for vaginal delivery; 0.019-0.021μg/L for Cesarean delivery; 0.049-5.537μg/L and 0.020-0.148μg/L for 3rd and 10th days after vaginal delivery, respectively; 0.022-0.724μg/L and 0.024-0.129μg/L for the 3rd and 10th days after Cesarean delivery, respectively; and 0.015-0.061μg/L for non-pregnant healthy women.
CONCLUSION: The RIs for PCT in pregnant women by trimester, days postpartum, and mode of delivery were established, thus providing a clinical reference for doctors.
Copyright © 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pregnant women; Procalcitonin; Reference intervals

Mesh:

Substances:

Year:  2016        PMID: 27776221     DOI: 10.1016/j.clinbiochem.2016.10.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

Review 1.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

2.  A risk score for early predicting bloodstream infections in febrile obstetric patients: a pilot study.

Authors:  Yaozong Zhang; Lan Li; Yunsheng Yan; Haifeng Qi; Jiali Qin; Li Ren; Ruoxuan Zhang
Journal:  Arch Gynecol Obstet       Date:  2021-10-03       Impact factor: 2.493

3.  Procalcitonin in preterm rupture of membranes: a systematic review and meta-analysis.

Authors:  Ana Luísa Areia; Miguel Areia; Anabela Mota-Pinto
Journal:  Arch Gynecol Obstet       Date:  2020-10-03       Impact factor: 2.344

4.  Application of a Prediction Model Based on the Laboratory Index Score in Prelabor Rupture of Membranes with Histologic Chorioamnionitis During Late Pregnancy.

Authors:  Yan Ma; Yun Xu; Lijuan Jiang; Xiaonan Shao
Journal:  Med Sci Monit       Date:  2020-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.